pubmed-article:11814816 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0268563 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:11814816 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
pubmed-article:11814816 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11814816 | pubmed:dateCreated | 2002-3-7 | lld:pubmed |
pubmed-article:11814816 | pubmed:abstractText | Synthesis and SARs of new integrin alpha(V)beta(3) antagonists based on an N-substituted dibenzazepinone scaffold are described. Variation of spacer and guanidine mimetic led to potent compounds exhibiting an IC(50) towards alpha(V)beta(3) in the nanomolar range, high selectivity versus integrin alpha(IIb)beta(3) and efficacy in functional cellular assays. | lld:pubmed |
pubmed-article:11814816 | pubmed:language | eng | lld:pubmed |
pubmed-article:11814816 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11814816 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11814816 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11814816 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11814816 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:KlingAndreasA | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:BackfischGise... | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:DelzerJürgenJ | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:GenesteHervéH | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:GraefClaudiaC | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:HolzenkampUta... | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:HornbergerWil... | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:LangeUdo E... | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:LauterbachArn... | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:MackHelmutH | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:SeitzWernerW | lld:pubmed |
pubmed-article:11814816 | pubmed:author | pubmed-author:SubkowskiThom... | lld:pubmed |
pubmed-article:11814816 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11814816 | pubmed:day | 11 | lld:pubmed |
pubmed-article:11814816 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:11814816 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11814816 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11814816 | pubmed:pagination | 441-6 | lld:pubmed |
pubmed-article:11814816 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:meshHeading | pubmed-meshheading:11814816... | lld:pubmed |
pubmed-article:11814816 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11814816 | pubmed:articleTitle | Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists. | lld:pubmed |
pubmed-article:11814816 | pubmed:affiliation | Knoll GmbH, D-67008 Ludwigshafen, Germany. andreas.kling@abbott.de | lld:pubmed |
pubmed-article:11814816 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:11814816 | lld:chembl |